DRI Healthcare Trust (TSE:DHT.UN – Get Free Report)’s share price rose 1.4% during mid-day trading on Friday . The stock traded as high as C$12.20 and last traded at C$12.12. Approximately 30,567 shares traded hands during mid-day trading, a decline of 18% from the average daily volume of 37,483 shares. The stock had previously closed at C$11.95.
Wall Street Analyst Weigh In
Several brokerages have recently commented on DHT.UN. CIBC lowered their price objective on shares of DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating for the company in a research note on Thursday, December 12th. Raymond James decreased their target price on DRI Healthcare Trust from C$23.00 to C$22.00 in a report on Wednesday, November 13th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, DRI Healthcare Trust presently has an average rating of “Moderate Buy” and an average target price of C$17.94.
Read Our Latest Analysis on DRI Healthcare Trust
DRI Healthcare Trust Trading Up 1.4 %
DRI Healthcare Trust Company Profile
DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.
Further Reading
- Five stocks we like better than DRI Healthcare Trust
- Dividend Capture Strategy: What You Need to Know
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is the NASDAQ Stock Exchange?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Where Do I Find 52-Week Highs and Lows?
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.